Industry News
Pharmaceutical Industry News
What Happens When You Stop Taking Ozempic and Wegovy?
As more patients turn to diabetes medications for other uses, a shortage has taken hold. But doctors say going off these drugs can take a toll.
GoodRx Leaked User Health Data to Facebook and Google, F.T.C. Says
The popular drug discount app deceptively shared details on users’ illnesses and medicines with ad firms, regulators said in a legal complaint.
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
Women Have Been Misled About Menopause
Hot flashes, sleeplessness, pain during sex: For some of menopause’s worst symptoms, there’s an established treatment. Why aren’t more women offered it?
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
Why Experts Are Urging Swifter Treatment for Children With Obesity
Growing research has shown that intensive interventions are needed, scientists say. Here is why their advice is changing.
Start-Up Paradigm Raises $200 Million to Speed Up Drug Trials
New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
Covid Vaccines Targeting Omicron Should Be Standard, Panel Says
As advisers to the Food and Drug Administration endorsed ending one era of the Covid vaccination campaign, they also grappled with its future.
Rostro Ozempic: los efectos de los fármacos para perder peso en la cara
Las personas que usan medicamentos como Ozempic están encontrando un efecto secundario no deseado: envejecimiento facial.
A Farmer Secretly Paid for His Neighbors’ Prescriptions for Years
Hody Childress brought cash every month to a pharmacist in Alabama, asking her to use it to help people buy medicine. The town learned of the arrangement only after his death.
A Dilemma for Governments: How to Pay for Million-Dollar Therapies
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
Those Weight Loss Drugs May Do a Number on Your Face
People using drugs like Ozempic are discovering an unwanted side effect: facial aging.
I Lost Weight on Ozempic. Here’s What the Debate Gets Wrong.
Why one doctor believes obesity should be treated like any disease — with medication.
Why Kids’ Medication Shortages Aren’t Going Away
There are weaknesses baked into the supply chain.
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.
California Sues Companies Over Insulin Prices, Joining Other States
The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
Medicare Begins to Rein In Drug Costs for Older Americans
Reforms embedded in the Inflation Reduction Act will bring savings to seniors this year. Already some lawmakers are aiming to repeal the changes.
Paxlovid para covid: ¿quién debería tomarlo?
Los expertos dicen que tomar este antiviral ayuda a evitar algunos síntomas persistentes de covid y la hospitalización. Pero los malentendidos impiden que más personas tomen el fármaco.
FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says
Mifepristone, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies. Now, if local drugstores or chains like CVS agree to certain rules,